Pharsight

Labs Juvise patents expiration

1. Pylera patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6350468 LABS JUVISE Double capsule for the administration of active principles in multiple therapies
Dec, 2018

(5 years ago)

Drugs and Companies using BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 28 September, 2006

Treatment: Treatment of patients with h. pylori infection and duodenal ulcer disease

Dosage: CAPSULE;ORAL

How can I launch a generic of PYLERA before it's drug patent expiration?
More Information on Dosage

PYLERA family patents

Family Patents